| scholarly article | Q13442814 |
| P356 | DOI | 10.4269/AJTMH.2011.10-0624 |
| P724 | Internet Archive ID | pubmed-PMC3083745 |
| P932 | PMC publication ID | 3083745 |
| P698 | PubMed publication ID | 21540387 |
| P5875 | ResearchGate publication ID | 51096245 |
| P50 | author | Shawn T. Brown | Q55816037 |
| Rachel B. Slayton | Q56774942 | ||
| Derek Cummings | Q60057514 | ||
| Bruce Y. Lee | Q65555428 | ||
| Donald H Burke | Q89069675 | ||
| Yongjua Laosiritaworn | Q92251882 | ||
| Kristina M Bacon | Q114780920 | ||
| Mirat Shah | Q117231530 | ||
| P2093 | author name string | Diana L Connor | |
| Sarah B Kitchen | |||
| P2860 | cites work | Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered | Q24736974 |
| Serotype-Specific Differences in the Risk of Dengue Hemorrhagic Fever: An Analysis of Data Collected in Bangkok, Thailand from 1994 to 2006 | Q27491001 | ||
| A prospective study of dengue infections in Bangkok | Q28296365 | ||
| Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak | Q29619424 | ||
| Evidence That Maternal Dengue Antibodies Are Important in the Development of Dengue Hemorrhagic Fever in Infants | Q29620637 | ||
| Consequences of the expanding global distribution of Aedes albopictus for dengue virus transmission | Q33592996 | ||
| Pricing of new vaccines | Q34663970 | ||
| Concomitant or sequential administration of live attenuated Japanese encephalitis chimeric virus vaccine and yellow fever 17D vaccine: randomized double-blind phase II evaluation of safety and immunogenicity | Q34694967 | ||
| Progress towards a dengue vaccine | Q35009119 | ||
| Decreases in dengue transmission may act to increase the incidence of dengue hemorrhagic fever | Q36883189 | ||
| Estimating the costs of achieving the WHO-UNICEF Global Immunization Vision and Strategy, 2006-2015. | Q37108533 | ||
| Constructing target product profiles (TPPs) to help vaccines overcome post-approval obstacles | Q37603633 | ||
| Dengue vaccine candidates in development | Q37608075 | ||
| Burden of symptomatic dengue infection in children at primary school in Thailand: a prospective study | Q38874657 | ||
| Cost effectiveness of Aedes aegypti control programmes: participatory versus vertical | Q38890588 | ||
| Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study | Q39038308 | ||
| Cost-effectiveness of annual targeted larviciding campaigns in Cambodia against the dengue vector Aedes aegypti | Q39813772 | ||
| A novel tetravalent dengue vaccine is well tolerated and immunogenic against all 4 serotypes in flavivirus-naive adults | Q40369287 | ||
| A dengue transmission model in Thailand considering sequential infections with all four serotypes | Q40375597 | ||
| Recent progress on sanofi pasteur's dengue vaccine candidate | Q40378149 | ||
| Cost of dengue cases in eight countries in the Americas and Asia: a prospective study. | Q40390836 | ||
| Yellow fever vaccine-associated viscerotropic disease (YEL-AVD) and corticosteroid therapy: eleven United States cases, 1996-2004. | Q40472934 | ||
| Cost-effectiveness of a pediatric dengue vaccine | Q40538985 | ||
| Guidelines on the cost-effectiveness of larval control programs to reduce dengue transmission in Puerto Rico | Q40551062 | ||
| A study of fatal hemorrhagic dengue cases in Cuba, 1981. | Q40830518 | ||
| Immunogenicity, safety and tolerability in adults of a new single-dose, live-attenuated vaccine against Japanese encephalitis: Randomised controlled phase 3 trials | Q57080491 | ||
| Safety and immunogenicity of a single administration of live-attenuated Japanese encephalitis vaccine in previously primed 2- to 5-year-olds and naive 12- to 24-month-olds: multicenter randomized controlled trial | Q85057708 | ||
| Race is on for effective dengue vaccine | Q85160393 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Thailand | Q869 |
| vaccine | Q134808 | ||
| Dengue virus | Q476209 | ||
| P304 | page(s) | 764-772 | |
| P577 | publication date | 2011-05-01 | |
| P1433 | published in | American Journal of Tropical Medicine and Hygiene | Q15766943 |
| P1476 | title | Economic value of dengue vaccine in Thailand | |
| P478 | volume | 84 |
| Q52638470 | A multi-country study of dengue vaccination strategies with Dengvaxia and a future vaccine candidate in three dengue-endemic countries: Vietnam, Thailand, and Colombia |
| Q48031367 | A systems approach to vaccine decision making |
| Q38156746 | An economic evaluation of vector control in the age of a dengue vaccine |
| Q38517709 | Assessing the Economics of Dengue: Results from a Systematic Review of the Literature and Expert Survey |
| Q21562250 | Controlling dengue with vaccines in Thailand |
| Q90788888 | Cost effectiveness of dengue vaccination following pre-vaccination serological screening in Sri Lanka |
| Q34493023 | Cost of dengue outbreaks: literature review and country case studies |
| Q33636857 | Cost-Effectiveness of Dengue Vaccination Programs in Brazil |
| Q36336154 | Cost-effectiveness of dengue vaccination in Yucatán, Mexico using a dynamic dengue transmission model |
| Q47578242 | Cost-effectiveness of dengue vaccination in ten endemic countries |
| Q39326565 | Cost-utility analysis of dengue vaccination in a country with heterogeneous risk of dengue transmission |
| Q37625631 | Country- and age-specific optimal allocation of dengue vaccines |
| Q38661075 | Current issues in the economics of vaccination against dengue |
| Q37391237 | Dengue Dynamics and Vaccine Cost-Effectiveness Analysis in the Philippines |
| Q40243587 | Dengue dynamics and vaccine cost-effectiveness in Brazil. |
| Q38201151 | Developing a dengue vaccine: progress and future challenges |
| Q36112173 | Dispersal of male Aedes aegypti in a coastal village in southern Mexico |
| Q36131929 | Economic Burden of Dengue Virus Infection at the Household Level Among Residents of Puerto Maldonado, Peru. |
| Q91977532 | Economic Evaluations of Dengue Vaccination in the Southeast Asia Region: Evidence From a Systematic Review |
| Q21092274 | Economic and disease burden of dengue in Southeast Asia |
| Q39332382 | Estimated economic impact of vaccinations in 73 low- and middle-income countries, 2001-2020. |
| Q34441930 | Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries |
| Q29994616 | Operations research in global health: a scoping review with a focus on the themes of health equity and impact |
| Q47216541 | Resource Use and Costs of Dengue: Analysis of Data from Phase III Efficacy Studies of a Tetravalent Dengue Vaccine |
| Q92610579 | Systematic review of health economic evaluation studies of dengue vaccines |
| Q38958463 | The Potential Cost Effectiveness of Different Dengue Vaccination Programmes in Malaysia: A Value-Based Pricing Assessment Using Dynamic Transmission Mathematical Modelling |
| Q30241840 | The economic promise of developing and implementing dengue vaccines: Evidence from a systematic review |
| Q36450782 | Total Economic Cost and Burden of Dengue in Nicaragua: 1996–2010 |
| Q34516283 | Transmission Dynamics of the Four Dengue Serotypes in Southern Vietnam and the Potential Impact of Vaccination |
| Q38032553 | Treatment of dengue fever |
| Q34232487 | Use of insecticide-treated school uniforms for prevention of dengue in schoolchildren: a cost-effectiveness analysis |
Search more.